Spondyloenchondrodysplasia with immune dysregulation: Role of sirolimus

Pediatr Blood Cancer. 2022 Oct;69(10):e29672. doi: 10.1002/pbc.29672. Epub 2022 Mar 16.

Authors

Gopinathan Mathiyazhagan¹, Faheema Hasan¹, Priyanka Chauhan¹, Anshul Gupta¹, Sanjeev Yadav¹, Rajesh Kashyap¹

Affiliation

¹ Department of Haematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

PMID: 35293682
DOI: 10.1002/pbc.29672

No abstract available

Publication types

Letter

MeSH terms

Autoimmune Diseases*
Humans
Immunologic Deficiency Syndromes
Immunosuppressive Agents
Osteochondrodysplasias* / drug therapy
Sirolimus / therapeutic use

Substances

Immunosuppressive Agents
Sirolimus

Supplementary concepts

Combined Immunodeficiency with Autoimmunity and Spondylometaphyseal Dysplasia
Spondyloenchondrodysplasia